InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
+12.0%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Dayno Jeffrey M., Directeur Médical. Insider active across 2 companies, notably Harmony Biosciences Holdings, Inc.. Aggregated, 17 disclosures have been recorded. Split: 0 buy · 1 sell. History available since 22 July 2021. The latest transaction was filed on 24 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
10,500 shares0Common StockSEC:0001415889-25-002159:0
19,293 shares@ US$8.2216.2% of flowCommon StockSEC:0001415889-25-001931:0
15,000 shares@ US$8.2213.4% of flowCommon StockSEC:0001415889-22-011083:0
15,000 shares@ US$8.2213.3% of flowCommon StockSEC:0001415889-22-010986:0
14,099 shares@ US$8.220.0057% mcap18.7% of flowCommon StockSEC:0001104659-21-128203:0
14,099 shares@ US$8.2210.6% of flowCommon StockSEC:0001104659-21-128203
1,800 shares@ US$8.220.0007% mcap2.4% of flowCommon StockSEC:0001104659-21-124273:0
1,800 shares@ US$8.221.4% of flowCommon StockSEC:0001104659-21-124273
10,000 shares@ US$8.220.0040% mcap13.0% of flowCommon StockSEC:0000899243-21-035505:0
10,000 shares@ US$8.227.4% of flowCommon StockSEC:0000899243-21-035505
2,159 shares@ US$8.220.0009% mcap2.8% of flowCommon StockSEC:0000899243-21-034517:0
2,159 shares@ US$8.221.6% of flowCommon StockSEC:0000899243-21-034517
9,950 shares@ US$8.220.0040% mcap13.1% of flowCommon StockSEC:0000899243-21-032526:0
9,950 shares@ US$8.227.4% of flowCommon StockSEC:0000899243-21-032526
50 shares@ US$8.220.0% of flowCommon StockSEC:0000899243-21-029687
50 shares@ US$8.220.0000% mcap0.1% of flowCommon StockSEC:0000899243-21-029687:0
536 sharesCommon StockSEC:0001179110-16-017045:0
17 of 17 declarations
About Dayno Jeffrey M.
Dayno Jeffrey M. is the Chief Medical Officer at Harmony Biosciences Holdings, Inc. In this role, he oversees the company's medical and clinical activities, ensuring innovation and regulatory compliance. His expertise in medicine and pharmaceutical product development is essential for achieving Harmony Biosciences's growth objectives.
